Achromatopsia: 2018 Pipeline Analysis by Company, Phase, Molecule Type, and Route of Administration – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Achromatopsia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments" report has been added to ResearchAndMarkets.com's offering. This report covers 3 drugs currently in different phases of development. The report provides Achromatopsia treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration a